Mammalian Genome · Nov 16, 2026

Taurine metabolism: a potential target for neuroprotection in age-related neurodegenerative diseases

By Daghini E, Tribble JR, Amato R et al.

Taurine is one of the most abundant free amino acids in mammals and plays essential roles in cellular homeostasis, mitochondrial function, calcium regulation and neuronal survival. Taurine availability varies markedly across tissues, species and sexes, reflecting the balance between endogenous synthesis, dietary intake, transport and efflux. Although reduced taurine levels have been reported in some aging tissues, recent longitudinal studies indicate that circulating taurine does not decline universally with age, and its value as a biomarker of aging remains debated. Alterations in taurine or its transporter SLC6A6 have been described in Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, multiple sclerosis, Huntington’s disease and retinal degenerations. Preclinical studies indicate that taurine supplementation mitigates excitotoxicity, stabilizes mitochondrial function, reduces neuroinflammation and supports myelination and synaptic balance. Despite this strong mechanistic rationale, clinical evidence remains limited and heterogeneous, underscoring the need for biomarker-guided trials and a clearer definition of optimal therapeutic windows. In this review, we summarize the general properties of taurine and its metabolic regulation. We examine taurine’s neuroprotective properties across different neurodegenerative conditions and discuss future perspectives for targeting taurine metabolism as a promising but largely unexplored strategy for intervention in age-related neurodegenerative diseases.

doi.org/10.1007/s00335-026-10292-7Open accessPubMed 43037734Interventions

AgingResearch.News